Open Access

Haplotype analysis of ApoAI gene and sepsis-associated acute lung injury

Lipids in Health and Disease201413:79

DOI: 10.1186/1476-511X-13-79

Received: 8 February 2014

Accepted: 10 April 2014

Published: 13 May 2014



Apolipoprotein A1 (ApoA1) is the major apoprotein constituent of high density lipoprotein (HDL) which exerts innate protective effects in systemic inflammation. However, its role in the acute lung injury (ALI) has not been well studied. In the present study we investigated the association between polymorphisms of ApoA1 gene and ALI in a Chinese population.


Three polymorphisms of the ApoA1 gene (rs11216153, rs2070665, and rs632153) were genotyped by TaqMan method in 290 patients with sepsis-associated ALI, 285 patients sepsis alone and 330 age- and sex-matched healthy controls.


We found rs11216153 polymorphism of ApoA1 was associated with ALI, the GG genotype and G allele was common in the ALI patients (76.9%, 88.1%, respectively) than both in the control subjects (55.8%, 75.8%, respectively) and in the sepsis alone patients (58.2%, 78.4%, respectively). Haplotype consisting of these three SNPs strengthened the association with ALI susceptibility. The frequency of haplotype GTG in the ALI samples was significantly higher than that in the healthy control group (OR = 2.261, 95% CI: 1.735 ~ 2.946, P <0.001) and the sepsis alone group (OR = 1.789, 95% CI: 1.373 ~ 2.331.P < 0.001). Carriers of the haplotype TTG had a lower risk for ALI compared with healthy control group (OR = 0.422, 95% CI: 0.310 ~ 0.574, P < 0.001) and sepsis alone group (OR = 0.491, 95% CI: 0.356 ~ 0.676, P <0.001).


These results indicated that genetic variants in the ApoA1 gene might be associated with susceptibility to sepsis-associated ALI in Han Chinese population.


ApoA1 Polymorphism Haplotype Acute lung injury


Acute lung injury (ALI) and its more severe form, the acute respiratory distress syndrome (ARDS), are syndromes of acute respiratory failure that are characterized by acute pulmonary edema and lung inflammation. ALI remains an important cause of death in the intensive care units (ICU) and few specific therapies are available [1]. Although sepsis, pneumonia, aspiration, trauma, pancreatitis and multiple transfusion are recognized as the most common causes of ALI, only a small fraction of patients with these risk factors develop ALI [2]. Clinical and epidemiological studies have supported the hypothesis that genetic factors might play a part in the development and outcome of ALI [310]. Identification of genetic variants may provide new insight into the molecular pathogenesis of ALI and lead to the development of new diagnostic and therapeutic targets [6]. The pathogenetic basis of ALI is incompletely understood.

However, emerging evidence has suggested that the severity and outcome of ALI depend significantly on systemic inflammatory response [11]. Apolipoprotein A1 (ApoA1) is the major apoprotein constituent of high density lipoprotein (HDL) which exerts innate protective effects in systemic inflammation [12]. However, its role in the acute lung injury (ALI) has not been well studied. Previous study [13] suggested that one variant residing in the ApoA1 gene, which involves a guanine to adenine transition 75 base pairs (bp) upstream from the start of transcription (G–75A) and destroys a site for the MspI restriction enzyme, was associated with ALI after cardiopulmonary bypass surgery. In their study, the authors only selected one single nucleotide polymorphism (−75 G > A) to perform a case–control study. And this is a hospital based case–control study, the selection bias cannot be avoidable and the subjects may not be representative of the general population.

In the present study, we established haplotypes of ApoA1 gene consisting of 3 SNPs (rs11216153, rs2070665, and rs632153) and to assess the relationship between these haplotypes and ALI in a Chinese population.

Material and methods


The present study was reviewed and approved by the Ethics Study Board of First Affiliated Hospital of Bengbu Medical College. Informed written consent was obtained from all subjects or from their legal surrogates before enrollment. Definitions of sepsis and ALI were in accordance with the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference [14] and the American-European Consensus Conference statements (AECC) [15].

All sepsis subjects enrolled had either severe sepsis or septic shock. All patients were selected from the Emergency and Respiratory ICUs at First Affiliated Hospital of Bengbu Medical College, and were treated according to the Surviving Sepsis Campaign guidelines [16]. Exclusion criteria included age below 18 years, severe chronic respiratory disease, severe chronic liver disease (defined as a Child-Pugh score of > 10), using of high-dose immunosuppressive therapy and AIDS patients. All sepsis patients were screened daily for ALI/ARDS development and those who fulfilled the AECC criteria for ALI/ARDS were considered as ALI cases, which included ALI and ARDS patients; whereas those patients who did not develop ALI/ARDS during hospital stay were considered as sepsis alone patients. Baseline characteristics of all patients were obtained during ICU stay. Sex- and age-matched controls were selected from healthy blood donors. We selected the control subjects aged 55–66 years, which was matched to the patients group. There are not significant difference between the control subjects and the ALI patients in age and in sex.

Questionnaires including smoking, chronic illness and the history of ALI or sepsis were obtained from all control subjects. Healthy controls were defined as individuals without any recent acute illness, any chronic illness and a history of ALI or sepsis. To reduce the potential confounding from ethnic backgrounds, we only enrolled people with self-reported origin of central Han Chinese.


There are 156 SNPs for the human ApoA1 gene listed in the National Center for Biotechnology Information SNP database ( As shown in Figure 1, using the Haploview 4.2 software and the HapMap phrase II database, we obtained three tagging SNPs (rs11216153, rs2070665, and rs632153) for Chinese Han using minor allele frequency (MAF) ≥0.05 and linkage disequilibrium patterns with r 2 ≥ 0.6 as a cutoff.
Figure 1

Genetic variation at human ApoA1 gene. Using the Haploview 4.2 software and the HapMap phrase II database, we scanned 5 genotyped single-nucleotide polymorphisms (SNPs) in Chinese Han. Linkage disequilibrium (LD) blocks across the locus in Chinese Han. LD block derived by solid spline method in Haploview 4.2. LD value shown: (A) |D’| × 100; |D’| colour scheme: |D’| =0: white; 0 < |D’| < 1: shades of pink; |D’| =1: red; (B) r 2 × 100; r 2 colour scheme: r 2 = 0: white; 0 < r 2 < 1: shades of grey; r 2 = 1: black.

Genomic DNA was extracted from the peripheral blood leukocytes using a DNA extraction Kit (Beijing Bioteke Co. Ltd). Genotyping was confirmed by TaqMan method as described previously [17].

Statistical analysis

The SPSS 17.0 for windows was used for the statistical analysis. For each polymorphism, Hardy-Weinberg equilibrium was assessed using the standard χ2 test or Fisher’s exact test. Genotype frequencies in cases and controls were compared by χ2 tests. The genotype-specific risks were estimated as odds ratios (ORs) and it’s 95% CI. Based on the genotype data of the genetic variations, we performed linkage disequilibrium (LD) analysis and haplotype-based case–control analysis, using the SHEsis software ( [18, 19]. In the haplotype-based case–control analysis, haplotypes with a frequency of <0.03 were excluded. Statistical significance was established at P <0.05.


Characteristics of the study population

The baseline characteristics of the study population are shown in Table 1. The primary source of infection was the lungs, involving 91.1% of the combined sample of sepsis alone and ALI patients. There was no significant difference in age, gender, BMI, diabetes, liver cirrhosis and history of smoking between ALI patients and sepsis alone patients (P >0.05).
Table 1

Demographic and clinical characteristics of subjects


Healthy controls

ALI patients

Sepsis alone patients

P value






Age, year

65.3 ± 10.2

63.8 ± 11.9

64.1 ± 10.7


Male (%)

186 (56.4)

172 (59.3)

170 (59.6)


BMI (kg.m−2)

21.1 ± 4.4

23.3 ± 4.8

23.1 ± 5.8


Diabetes (%)


56 (19.3)

51 (17.9)


Liver cirrhosis (%)


16 (5.5)

13 (4.6)


Smoker (%)

118 (34.2)

107 (36.9)

102 (35.8)


Sepsis insult (%)


   Lung (%)


265 (91.4)

262 (91.9)


   Abdomen (%)


7 (2.4)

8 (2.8)


   UTI (%)


5 (1.7)

4 (1.4)


   Bloodstream (%)


11 (3.8)

10 (3.5)


   Other (%)


2 (0.7)

1 (0.4)


Associations of the ApoA1 gene SNPs with ALI risk

Table 2 shows the distribution of the genotypes and alleles of these 3 SNPs. The genotype distribution of each SNP did not show significant difference from the Hardy-Weinberg equilibrium values (data not shown). We found rs11216153 polymorphism of ApoA1 was associated with ALI, the GG genotype and G allele was common in the ALI patients (76.9%, 88.1%, respectively) than both in the control subjects (55.8%, 75.8%, respectively, P < 0.001) and in the sepsis alone patients (58.2%, 78.4%, respectively, P < 0.001). However, we did not find any association of rs2070665 and rs632153 with ALI.
Table 2

Genotype distribution of ApoAI tag SNPs between case and control subjects


Genotype and allele

Control (n = 330)

ALI patients (n = 290)

Sepsis alone patients (n = 285)

P a

P b



184 (0.558)

223 (0.769)

166 (0.582)





132 (0.400)

65 (0.224)

115 (0.404)



14 (0.042)

2 (0.007)

4 (0.014)















101 (0.306)

80 (0.276)

83 (0.291)





181 (0.548)

161 (0.555)

159 (0.558)



48 (0.146)

49 (0.169)

43 (0.151)















281 (0.851)

246 (0.848)

241 (0.846)





47 (0.142)

43 (0.148)

43 (0.150)



2 (0.007)

1 (0.004)

1 (0.004)













Pa : ALI vs. control; Pb : ALI vs. Sepsis alone patients.

Associations of the ApoA1 gene haplotypes with ALI risk

As shown in Table 3 and Table 4, the frequency of haplotype GTG in the ALI samples was significantly higher than that in the healthy control group (OR = 2.261, 95% CI: 1.735 ~ 2.946, P <0.001) and the sepsis alone group (OR = 1.789, 95% CI: 1.373 ~ 2.331.P < 0.001). Carriers of the haplotype TTG had a lower risk for ALI compared with healthy control group (OR = 0.422, 95% CI: 0.310 ~ 0.574, P < 0.001) and sepsis alone group (OR = 0.491, 95% CI: 0.356 ~ 0.676, P <0.001).
Table 3

Distribution of haplotypes (ALI patients vs. healthy control)


ALI patients



OR (95% CI)


276.00 (0.476)

332.00 (0.503)


0.897 [0.717 ~ 1.121]


45.00 (0.078)

51.00 (0.077)


1.004 [0.662 ~ 1.525]


190.00 (0.328)

117.00 (0.177)


2.261 [1.735 ~ 2.946]


69.00 (0.119)

160.00 (0.242)


0.422 [0.310 ~ 0.574]

Table 4

Distribution of haplotypes (ALI patients vs. Sepsis alone patients)


ALI patients

Sepsis alone patients


OR (95% CI)


276.00 (0.476)

279.99 (0.491)


0.940 [0.746 ~ 1.185]


45.00 (0.078)

45.00 (0.079)


0.981 [0.638 ~ 1.509]


190.00 (0.328)

122.01 (0.214)


1.789 [1.373 ~ 2.331]


69.00 (0.119)

122.99 (0.216)


0.491 [0.356 ~ 0.676]


In the present study, we found ApoA1 gene polymorphisms and haplotypes were significant associated with ALI risk in a Chinese population. Some studies have been performed to find an association of genetic polymorphisms and ALI [20]. A prospective case–control study found that -607C/C genotype in IL-18 gene played a pivotal role in the development of ALI in Chinese Han population [21]. Another case–control study found that the IL-6 -572 polymorphism was associated with ALI [22]. Several studies have suggested that pre-B-cell colonyenhancing factor (PBEF) gene polymorphisms were associated with susceptibility and prognosis of ALI [23, 24]. The plasminogen activator inhibitor-1 (PAI-1) 4G allele was associated with worse outcome in ALI/ARDS [25]. A prospective cohort demonstrated that the AC genotype at position −1221 in the NQO1 gene caused decreased transcription and was associated with a lower incidence of ALI following major trauma [26]. In a nested case–control study, patients with the NRF2 -617 A allele had a significantly higher risk for developing ALI after major trauma [27]. A case–control study found that myosin light chain kinase (MYLK) genetic variants were associated with increased risk of sepsis-associated ALI [28].

The ApoA1 gene has recently been linked to many other diseases. A comparative study found that carrying the ApoA1 -75 A allele could confer a higher risk of hyperlipidemia in obese children [29]. A prospective case–control study found that the ApoA1 -75 G/A polymorphism influenced cholesterol metabolism [30]. A pilot study in a north Indian population suggested that the ApoA1 -75 G allele might be a susceptibility allele for myocardial infarction [31].

In our study, we genotyped 3 SNPs in ApoA1 in Chinese participants and assessed the association between ApoA1 and ALI using a haplotype-based case–control analysis. The rs11216153 significantly differed between ALI patients and control participants, indicating that the risk of ALI is increased in participants with the G allele of rs11216153. Morris and Kaplan found that for genes with multiple susceptibilities, analysis based on haplotypes has advantages over analysis based on individual SNPs [32]. Consequently, in the present study, we successfully established haplotypes for the ApoA1 gene from the different combination of the 3 SNPs. The frequency of the GTG was associated with increased risk for ALI. However, the TTG was associated with decreased risk for ALI.

Although we found rs11216153 was associated with ALI risk in the present study, this SNP was located in the non-coding region of ApoA1. Given that this SNP was tag SNP, it is more likely that rs11216153 is tagging other common or rare variants of the ApoA1 gene associated with ALI. Another possibility is that the association might be due to LD with variants from nearby genes. Exhaustive resequencing is required to find or rule out the possibility of an as-yet-unidentified causal SNP in LD with rs11216153. And further functional studies are needed to investigate whether the variants have an effect on ApoA1 mRNA stability and translatability.

This study has a number of strengths. First, a sepsis without ALI group was used for comparison to exclude the possibility of a false association with sepsis. Second, to minimize racial admixture, we focused on central Han Chinese patients, which could be regarded as one single homogenous population [23, 24]. Third, to reduce the heterogeneous etiologies for ALI, the present study only included patients whose primary etiology for ALI was sepsis.

Some limitations of this study should be noted. First of all, these results should be interpreted with caution because the population was only from China, which reduces the possibility of confounding from ethnicity, so it does not permit extrapolation of the results to other ethnic groups. Second, the sample size of this study is relatively small, which may not have enough statistical power to explore the real association. Third, this is a hospital based case–control study, so the selection bias cannot be avoidable and the subjects may not be representative of the general population.


In conclusion, the present results indicate that ALI is associated with the ApoA1 gene polymorphisms. The GTG haplotype appear to be a risk genetic marker and the TTG haplotypes might be protective factor of ALI in Chinese people.



We appreciate the help from Dr. Chen Shi, Shanghai Institute of Cell Research, Chinese Academy of Medical Sciences.

Authors’ Affiliations

ICU Departments, First Affiliated Hospital of Bengbu Medical College


  1. Matthay MA, Zimmerman GA, Esmon C, Bhattacharya J, Coller B, Doerschuk CM, Floros J, Gimbrone MA, Hoffman E, Hubmayr RD, Leppert M, Matalon S, Munford R, Parsons P, Slutsky AS, Tracey KJ, Ward P, Gail DB, Harabin AL: Future research directions in acute lung injury: summary of a NationalHeart, Lung, and Blood Institute working group. Am J Respir Crit Care Med. 2003, 167 (7): 1027-1035. 10.1164/rccm.200208-966WSView ArticlePubMedGoogle Scholar
  2. Ware LB, Matthay MA: The acute respiratory distress syndrome. N Engl J Med. 2000, 342 (18): 1334-1349. 10.1056/NEJM200005043421806View ArticlePubMedGoogle Scholar
  3. Adamzik M, Frey U, Sixt S, Knemeyer L, Beiderlinden M, Peters J, Siffert W: ACE I/D but not AGT (−6)A/G polymorphism is a risk factor for mortality in ARDS. Eur Respir J. 2007, 29 (3): 482-488. 10.1183/09031936.00046106View ArticlePubMedGoogle Scholar
  4. Arcaroli J, Sankoff J, Liu N, Allison DB, Maloney J, Abraham E: Association between urokinase haplotypes and outcome from infection-associated acute lung injury. Intensive Care Med. 2008, 34 (2): 300-307. 10.1007/s00134-007-0930-6View ArticlePubMedGoogle Scholar
  5. Su L, Zhai R, Sheu CC, Gallagher DC, Gong MN, Tejera P, Thompson BT, Christiani DC: Genetic variants in the angiopoietin-2 gene are associated with increased risk of ARDS. Intensive Care Med. 2009, 35 (6): 1024-1030. 10.1007/s00134-009-1413-8PubMed CentralView ArticlePubMedGoogle Scholar
  6. Jin X, Hu Z, Kang Y, Liu C, Zhou Y, Wu X, Liu J, Zhong M, Luo C, Deng L, Deng Y, Xie X, Zhang Z, Zhou Y, Liao X: Association of IL-10-1082 G/G genotype with lower mortality of acute respiratory distress syndrome in a Chinese population. Mol Biol Rep. 2012, 39: 1-4. 10.1007/s11033-010-0377-7View ArticlePubMedGoogle Scholar
  7. Garcia JG: Searching for candidate genes in acute lung injury: SNPs, Chips and PBEF. Trans Am Clin Climatol Assoc. 2005, 116: 205-219.PubMed CentralPubMedGoogle Scholar
  8. Lagan AL1, Quinlan GJ, Mumby S, Melley DD, Goldstraw P, Bellingan GJ, Hill MR, Briggs D, Pantelidis P, du Bois RM, Welsh KI, Evans TW: Variation in iron homeostasis genes between patients with ARDS and healthy control subjects. Chest. 2008, 133 (6): 1302-1311. 10.1378/chest.07-1117View ArticlePubMedGoogle Scholar
  9. Medford AR, Keen LJ, Bidwell JL, Millar AB: Vascular endothelial growth factor gene polymorphism and acute respiratory distress syndrome. Thorax. 2005, 60 (3): 244-248. 10.1136/thx.2004.034785PubMed CentralView ArticlePubMedGoogle Scholar
  10. Flores C, Pino-Yanes Mdel M, Villar J: A quality assessment of genetic association studies supporting susceptibility and outcome in acute lung injury. Crit Care. 2008, 12 (5): R130- 10.1186/cc7098PubMed CentralView ArticlePubMedGoogle Scholar
  11. Schwartz MD, Moore EE, Moore FA, Shenkar R, Moine P, Haenel JB, Abraham E: Nuclear factor-kappa B is activated in alveolar macrophages from patients with acute respiratory distress syndrome. Crit Care Med. 1996, 24 (8): 1285-1292. 10.1097/00003246-199608000-00004View ArticlePubMedGoogle Scholar
  12. Albahrani AI, Usher JJ, Alkindi M, Marks E, Ranganath L, Al-yahyaee S: ApolipoproteinA1–75 G/A (M1-) polymorphism and lipoprotein(a); anti- vs. pro-Atherogenic properties. Lipids Health Dis. 2007, 6: 19- 10.1186/1476-511X-6-19PubMed CentralView ArticlePubMedGoogle Scholar
  13. Tu J, Zhang B, Chen Y, Liang B, Liang D, Liu G, He F: Association of apolipoprotein A1–75 G/A polymorphism with susceptibility to the development of acute lung injury after cardiopulmonary bypass surgery. Lipids Health Dis. 2013, 12: 172- 10.1186/1476-511X-12-172PubMed CentralView ArticlePubMedGoogle Scholar
  14. Cohen IL: Guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1993, 21: 476-477. 10.1097/00003246-199303000-00030.View ArticlePubMedGoogle Scholar
  15. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, LeGall JR, Morris A, Spragg R: Report of the American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes and clinical trial coordination. The Consensus Committee. Intensive Care Med. 1994, 20 (3): 225-232. 10.1007/BF01704707View ArticlePubMedGoogle Scholar
  16. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb SA, Beale RJ, Vincent JL, Moreno R, Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup: Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med. 2004, 32 (3): 858-873. 10.1097/01.CCM.0000117317.18092.E4View ArticlePubMedGoogle Scholar
  17. Xie X, Ma YT, Fu ZY, Yang YN, Ma X, Chen BD, Wang YH, Liu F: Haplotype analysis of the CYP8A1 gene associated with myocardial infarction. Clin Appl Thromb Hemost. 2009, 15 (5): 574-580. 10.1177/1076029608329581View ArticleGoogle Scholar
  18. Shi YY, He L: SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res. 2005, 15 (2): 97-98. 10.1038/ ArticlePubMedGoogle Scholar
  19. Li Z, Zhang Z, He Z, Tang W, Li T, Zeng Z, He L, Shi Y: A partition-ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis. Cell Res. 2009, 19: 519-523., 10.1038/cr.2009.33View ArticlePubMedGoogle Scholar
  20. Reddy AJ, Kleeberger SR: Genetic polymorphisms associated with acute lung injury. Pharmacogenomics. 2009, 10: 1527-1539. 10.2217/pgs.09.89PubMed CentralView ArticlePubMedGoogle Scholar
  21. Chen S, Xu L, Tang J: Association of interleukin 18 gene polymorphism with susceptibility to the development of acute lung injury after cardiopulmonary bypass surgery. Tissue Antigens. 2010, 76: 245-249. 10.1111/j.1399-0039.2010.01506.xView ArticlePubMedGoogle Scholar
  22. Wang JF, Bian JJ, Wan XJ, Zhu KM, Sun ZZ, Lu AD: Association between inflammatory genetic polymorphism and acute lung injury after cardiac surgery with cardiopulmonary bypass. Med Sci Monit. 2010, 16: CR260-CR265.PubMedGoogle Scholar
  23. Liu Y, Shao Y, Yu B, Sun L, Lv F: Association of PBEF gene polymorphisms with acute lung injury, sepsis, and pneumonia in a northeastern Chinese population. Clin Chem Lab Med. 2012, 50: 1917-1922.PubMedGoogle Scholar
  24. Bajwa EK, Yu CL, Gong MN, Thompson BT, Christiani DC: Pre-B-cell colonyenhancing factor gene polymorphisms and risk of acute respiratory distress syndrome. Crit Care Med. 2007, 35: 1290-1295. 10.1097/01.CCM.0000260243.22758.4FView ArticlePubMedGoogle Scholar
  25. Tsangaris I, Tsantes A, Bonovas S, Lignos M, Kopterides P, Gialeraki A, Rapti E, Orfanos S, Dimopoulou I, Travlou A, Armaganidis A: The impact of the PAI-1 4G/5G polymorphism on the outcome of patients with ALI/ARDS. Thromb Res. 2009, 123: 832-836. 10.1016/j.thromres.2008.07.018View ArticlePubMedGoogle Scholar
  26. Reddy AJ, Christie JD, Aplenc R, Fuchs B, Lanken PN, Kleeberger SR: Association of human NAD(P)H: quinone oxidoreductase 1 (NQO1) polymorphism with development of acute lung injury. J Cell Mol Med. 2009, 13: 1784-1791. 10.1111/j.1582-4934.2008.00581.xPubMed CentralView ArticlePubMedGoogle Scholar
  27. Marzec JM, Christie JD, Reddy SP, Jedlicka AE, Vuong H, Lanken PN, Aplenc R, Yamamoto T, Yamamoto M, Cho HY, Kleeberger SR: Functional polymorphisms in the transcription factor NRF2 in humans increase the risk of acute lung injury. FASEB J. 2007, 21: 2237-2246. 10.1096/fj.06-7759comView ArticlePubMedGoogle Scholar
  28. Gao L1, Grant A, Halder I, Brower R, Sevransky J, Maloney JP, Moss M, Shanholtz C, Yates CR, Meduri GU, Shriver MD, Ingersoll R, Scott AF, Beaty TH, Moitra J, Ma SF, Ye SQ, Barnes KC, Garcia JG: Novel polymorphisms in the myosin light chain kinase gene confer risk for acute lung injury. Am J Respir Cell Mol Biol. 2006, 34: 487-495. 10.1165/rcmb.2005-0404OCPubMed CentralView ArticlePubMedGoogle Scholar
  29. Toptas B, Gormus U, Ergen A, Gurkan H, Kelesoglu F, Darendeliler F, Bas F, Dalan AB, Izbirak G, Isbir T: Comparison of lipid profiles with APOA1 MspI polymorphism in obese children with hyperlipidemia. In Vivo. 2011, 25: 425-430.PubMedGoogle Scholar
  30. Smach MA, Edziri H, Charfeddine B, Ben Othman L, Lammouchi T, Ltaief A, Nafati S, Dridi H, Bennamou S, Limem K: Polymorphism in apoA1 influences high-density lipoprotein cholesterol levels but is not a major risk factor of alzheimer’s disease. Dement Geriatr Cogn Dis Extra. 2011, 1: 249-257. 10.1159/000329910PubMed CentralView ArticlePubMedGoogle Scholar
  31. Dawar R, Gurtoo A, Singh R: Apolipoprotein A1 gene polymorphism (G-75A and C + 83 T) in patients with myocardial infarction: a pilot study in a north Indian population. Am J Clin Pathol. 2010, 134: 249-255. 10.1309/AJCPKPTXQ3QN1IFGView ArticlePubMedGoogle Scholar
  32. Morris RW, Kaplan NL: On the advantage of haplotype analysis in the presence of multiple disease susceptibility alleles. Genet Epidemiol. 2002, 23 (3): 221-233. 10.1002/gepi.10200View ArticlePubMedGoogle Scholar


© Hao and He; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.